Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

6.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR T cells: The next frontier.

Cytotherapy·2026
Same author

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Nature communications·2026
Same author

Cancer-associated and non-neoplastic fibrosis: Comparative mechanisms and emerging antifibrotic strategies.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center.

Frontiers in digital health·2026
Same author

A nanobody-stem cell platform targeting innate and adaptive immune axis in the tumour microenvironment.

EBioMedicine·2026
Same author

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications.

NPJ breast cancer·2025
Same journal

Barbatolic Acid Prevents Tau and Amylin Interaction and Stimulates the Growth of Acetylated Microtubules in Cell Culture.

Current drug targets·2026
Same journal

Harnessing HIF-1α for Diabetic Wound Healing: From Molecular Insights to Therapeutic Strategies.

Current drug targets·2026
Same journal

Extracellular Vesicles from Mesenchymal Stem Cells Alleviate Spinal Cord Injury via the miR-486-5p/PTEN/PI3K/AKT Pathway.

Current drug targets·2026
Same journal

Improving B-cell Linear Epitope Prediction <i>via</i> Multiple Feature Fusion and an Integrated Machine Learning Algorithm.

Current drug targets·2026
Same journal

Mechanistic Insights into the Inhibition of Plasmodium falciparum DNA Gyrase A by Withanolide Derivatives through Integrated Computational Analysis.

Current drug targets·2026
Same journal

Epitranscriptomics in Breast Cancer: The Unveiled Role of RNA Modifications.

Current drug targets·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

10.5K

Tumor Stroma Manipulation By MSC.

Giulia Grisendi, Carlotta Spano, Filippo Rossignoli

  • 1Laboratory of Cellular Therapy Department of Medical and Surgical Sciences for Children & Adults University-Hospital of Modena and Reggio Emilia Via del Pozzo 71, 41124 Modena, Italy. massimo.dominici@unimore.it.

Current Drug Targets
|March 9, 2016
PubMed
Summary
This summary is machine-generated.

Tumor stroma (TS) is crucial in cancer progression. Manipulating TS with multipotent mesenchymal stromal/stem cells (MSC) shows promise for targeted cancer therapy, inducing tumor cell death with minimal toxicity.

More Related Videos

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

10.2K
Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 24, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
07:20

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery

Published on: February 28, 2020

10.5K
Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
05:48

Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion

Published on: March 18, 2014

10.2K
Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
09:18

Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion

Published on: April 4, 2025

1.3K

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Cancer Immunology

Background:

  • Tumor stroma (TS) critically influences cancer development, including oncogenesis, immune evasion, and drug resistance.
  • Understanding cancer cell-stromal interactions is vital for developing new therapeutic strategies.
  • Multipotent mesenchymal stromal/stem cells (MSC) are explored as potential anti-cancer agents targeting TS.

Purpose of the Study:

  • To investigate fundamental interactions between cancer cells and their stromal counterparts.
  • To explore the potential of MSC-mediated TS manipulation for anti-cancer therapies.
  • To evaluate the efficacy and safety of MSC-based strategies in targeting tumor growth.

Main Methods:

  • In vitro and in vivo studies analyzing cancer cell-stromal interactions.
  • Utilizing multimodal-armed MSC engineered to deliver apoptosis-inducing agents.
  • Assessing MSC localization, tumor targeting, and therapeutic effects in cancer models.

Main Results:

  • MSC demonstrated the ability to target various cancers in vitro.
  • In vivo studies showed MSC localization within tumors, mediating cancer cell death.
  • No significant toxicities were observed in normal tissues following MSC injection.

Conclusions:

  • TS manipulation using MSC represents a novel therapeutic avenue for cancer treatment.
  • MSC-based strategies offer a promising approach for influencing cancer cell fate.
  • Further research is needed to fully elucidate and optimize these anti-cancer strategies.